Literature DB >> 27446695

Lowering photosensitizer doses and increasing fluences induce apoptosis in tumor bearing mice.

Katja Haedicke1, Susanna Graefe2, Ulf Teichgraeber1, Ingrid Hilger1.   

Abstract

The objective of this study was to determine an optimal dose of photodynamic therapy (PDT) for inducing apoptotic tumor cells in vivo. In this context, mice bearing human tongue-squamous epithelium carcinomas were treated with various photosensitizer concentrations and fluences. Tumor apoptosis was imaged after 2 days via a self-designed DY-734-annexin V probe using near-infrared fluorescence (NIRF) optical imaging. Apoptosis was verified ex vivo via TUNEL staining. Apoptotic tumor cells were detected in vivo at a dose of 40 µg photosensitizer and a fluency of 100 J/cm(2). This is the lowest photosensitizer dose reported so far.

Entities:  

Keywords:  (000.1430) Biology and medicine; (170.0110) Imaging systems; (170.0170) Medical optics and biotechnology; (170.5380) Physiology

Year:  2016        PMID: 27446695      PMCID: PMC4948619          DOI: 10.1364/BOE.7.002641

Source DB:  PubMed          Journal:  Biomed Opt Express        ISSN: 2156-7085            Impact factor:   3.732


  16 in total

1.  Dosimetry in photodynamic therapy: oxygen and the critical importance of capillary density.

Authors:  T H Foster; L Gao
Journal:  Radiat Res       Date:  1992-06       Impact factor: 2.841

2.  Real-time monitoring of in vivo acute necrotic cancer cell death induced by near infrared photoimmunotherapy using fluorescence lifetime imaging.

Authors:  Takahito Nakajima; Kohei Sano; Makoto Mitsunaga; Peter L Choyke; Hisataka Kobayashi
Journal:  Cancer Res       Date:  2012-07-16       Impact factor: 12.701

3.  Multiplexed in vivo fluorescence optical imaging of the therapeutic efficacy of photodynamic therapy.

Authors:  Katja Haedicke; Susanna Gräfe; Frank Lehmann; Ingrid Hilger
Journal:  Biomaterials       Date:  2013-09-17       Impact factor: 12.479

4.  Compartmental targeting for mTHPC-based photodynamic treatment in vivo: Correlation of efficiency, pharmacokinetics, and regional distribution of apoptosis.

Authors:  Julie Garrier; Aude Bressenot; Susanna Gräfe; Sophie Marchal; Soumya Mitra; Thomas H Foster; François Guillemin; Lina Bezdetnaya
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-23       Impact factor: 7.038

5.  Metronomic photodynamic therapy as a new paradigm for photodynamic therapy: rationale and preclinical evaluation of technical feasibility for treating malignant brain tumors.

Authors:  Stuart K Bisland; Lothar Lilge; Annie Lin; Robert Rusnov; Brian C Wilson
Journal:  Photochem Photobiol       Date:  2004 Jul-Aug       Impact factor: 3.421

6.  Correlation between in vivo pharmacokinetics, intratumoral distribution and photodynamic efficiency of liposomal mTHPC.

Authors:  Henri-Pierre Lassalle; Dominique Dumas; Susanna Gräfe; Marie-Ange D'Hallewin; François Guillemin; Lina Bezdetnaya
Journal:  J Control Release       Date:  2008-11-28       Impact factor: 9.776

7.  Optimisation of illumination for photodynamic therapy with mTHPC on normal colon and a transplantable tumour in rats.

Authors:  H Tsutsui; A J MacRobert; A Curnow; A Rogowska; G Buonaccorsi; H Kato; S G Bown
Journal:  Lasers Med Sci       Date:  2002       Impact factor: 3.161

8.  Photodynamic therapy with conventional and PEGylated liposomal formulations of mTHPC (temoporfin): comparison of treatment efficacy and distribution characteristics in vivo.

Authors:  Vadzim Reshetov; Henri-Pierre Lassalle; Aurélie François; Dominique Dumas; Sebastien Hupont; Susanna Gräfe; Vasco Filipe; Wim Jiskoot; François Guillemin; Vladimir Zorin; Lina Bezdetnaya
Journal:  Int J Nanomedicine       Date:  2013-10-08

9.  Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy.

Authors:  Zeynep Alkin; Irfan Perente; Abdullah Ozkaya; Dilek Alp; Alper Agca; Ebru Demet Aygit; Selcuk Korkmaz; Ahmet Taylan Yazici; Ahmet Demirok
Journal:  Clin Ophthalmol       Date:  2014-04-05

Review 10.  Advances in the management of squamous cell carcinoma of the head and neck.

Authors:  Jean-Pascal Machiels; Maarten Lambrecht; François-Xavier Hanin; Thierry Duprez; Vincent Gregoire; Sandra Schmitz; Marc Hamoir
Journal:  F1000Prime Rep       Date:  2014-06-02
View more
  1 in total

1.  SHG-enhanced NIR-excited in vitro photodynamic therapy using composite nanoparticles of barium titanate and rose Bengal.

Authors:  Xianhe Sun; Zhang Ji; Sailing He
Journal:  RSC Adv       Date:  2019-03-11       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.